Zink biomarkers may detect breast cancer.

zink Researchers from the have published a study in the journal of the Royal Society of Chemistry journal Metallomics revealing that zinc can act as a bio-marker for possibly allowing for early detection of .

The pilot study examined zinc in the blood and blood serum of ten subjects (five patients and five healthy controls) alongside a range of samples from patients.

The researchers were able to show that they could detect key differences in zinc caused when cancer subtly alters the way that cells process the metal. Similar changes in copper in one of the patients is additional evidence that it may be possible to identify a biomarker for early that could form the basis of a simple, non-invasive, diagnostic blood test.

‘It has been known for over a decade that tissues contain high concentrations of zinc but the exact molecular mechanisms that might cause this have remained a mystery,’ said Dr Fiona Larner of ’s Department of Earth Sciences, who led the .

‘Our work shows that techniques commonly used in earth sciences can help us to understand not only how zinc is used by tumour cells but also how can lead to changes in zinc in an individual’s blood — holding out the promise of an easily-detectable biomarker of early .’

‘The hope is that this is the beginning of a whole new approach,’ said Dr Larner. ‘Understanding how different cancers alter different trace metals within the body could enable us to develop both new diagnostic tools and new treatments that could lead to a ‘two-pronged’ attack on many cancers. Further is already underway to see what changes in other metals may be caused by other cancers.’


Fiona Larner, Laura N. Woodley, Sami Shousha, Ashley Moyes, Emma Humphreys-Williams, Stanislav Strekopytov, Alex N. Halliday, Mark Rehkämper, R. Charles Coombes. Zinc isotopic compositions of tissue. Metallomics, 2014; DOI: 10.1039/C4MT00260A

Be Sociable, Share!

    Leave a Reply

    Your email address will not be published. Required fields are marked *